About
Technology
Issues
FAQ
Links
Official Page
DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.